Open AccessMonocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database
Author(s) -
Azeb Yirga,
Taofik Oyekunle,
Lauren E. Howard,
Amanda M. De Hoedt,
Matthew R. Cooperberg,
Christopher J. Kane,
William J. Aronson,
Martha K. Terris,
Christopher L. Amling,
Emanuela Taioli,
Jay H. Fowke,
Zachary Klaanssen,
Stephen J. Freedland,
Adriana C. Vidal
Publication year - 2021
Publication title -
ccc. cancer causes and control/ccc, cancer causes and control
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.073
H-Index - 134
eISSN - 1573-7225
pISSN - 0957-5243
DOI - 10.1007/s10552-020-01373-2
Subject(s) - medicine , prostate cancer , monocyte , hazard ratio , prostatectomy , proportional hazards model , white blood cell , oncology , cancer , confidence interval
Circulating inflammatory markers may predict prostate cancer (PC) outcomes. For example, a recent study showed that higher peripheral blood monocyte counts were associated with aggressive PC in Asian men undergoing radical prostatectomy (RP). Herein, we investigated whether peripheral monocyte count can predict long-term PC outcomes after RP in black and white men.